Atlas Oncology Partners operates a value-based oncology enablement platform supporting community oncology practices.
Atlas Oncology Partners has raised $28.0M in total funding. The most recent round was Series A. The last funding was announced in February 2026.
Atlas Oncology Partners's investors include Flare Capital Partners, Rubicon Founders.
Atlas Oncology Partners is headquartered in Nashville, United States.
Atlas Oncology Partners operates a value-based oncology enablement platform supporting community oncology practices.
Atlas Oncology Partners is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atlas Oncology Partners — Funding & Investors." VCBacked, February 11, 2026, https://www.vcbacked.co/company/atlas-oncology-partners. Accessed September 30, 2026.
VCBacked. (2026). Atlas Oncology Partners — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/atlas-oncology-partners
{{cite web |title=Atlas Oncology Partners — Funding & Investors |url=https://www.vcbacked.co/company/atlas-oncology-partners |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated